• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: June 7-11, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

June 7-11, 2010
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/7/10Washington, DCJanet WoodcockN/ASpeech at the Institute of Medicine Drug Safety Study
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/7/10Washington, DCMurray Lumpkin, Sandy KwederPaul Popmerantz, Linda Temple (Drug Information Association)Meet and greet
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs6/8/10Silver Spring, MDMurray Lumpkin, Kate Bond, Mary Lou Valdez, Sylvia Kim, Josephine TropeaIra Magaziner, David Ellis, Ed Wood, Inder Singh (Clinton Health Access Initiative)Strengthening Regulatory Capacity in the Developing World
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/7/10Portland, ORAlan BennettMembers of the Oregon Board of PharmacyCollaboration with FDA
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/7/10Portland, ORN/AAttendees at the Council of State and Territorial Epidemiologists (CSTE) Annual ConferenceOpening Plenary: The Past as Prelude: Federal and State Perspectives on Public Health in the Coming Decade
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/8/10Cincinnati, OHN/AAttendees at the Association of Public Health Laboratories Annual MeetingSpeech: Report from the US Food and Drug Administration
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/9/10Silver Spring, MDJohn Taylor, Linda KatzDan Brestle (The Esteee Lauder Companies); Joseph Healy (Kolmar Labs Group); David Holl (Mary Kay, Inc.); Linda Marshall (Elsyee Scientific Cosmetics); Jack Nethercutt (Merle Norman Cosmetics); Lezlee Westine, Betsy Anderson, John Bailey, John Hurson, Mark Pollack (Personal Care Products Council); Frankie Trull (Policy Directions Inc.)Cosmetics Policy
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/10/10Washington, DCN/AN/ASpeech at the Coalition Against Major Diseases Database Launch
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/10/10Silver Spring, MDGerald Dal Pan, John Jenkins, Rick Pazdur, and Jeff O’NeillAllen Lichter, Deborah Kamin, Karen Hagerty, Shelagh Foster, Suanna Bruinooge, Cindi Stephens (American Society of Clinical Oncology)REMS programs for oncology drug products
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs6/10/10Silver Spring, MDJeff O’NeillBill Marth, Debra Barrett (Teva Pharmaceuticals); William Burke, Kathy Kulkarni (Rubicon Advisors)Generic Drugs
Russell Abbott, Deputy Commissioner for Administration6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine6/9/10TeleconferenceMerton Smith, Kevin Greenlees, Margaret Oeller, Brandi Robinson, Jon Scheid, Steve Vaughn, Shena Arellano, Janice SorethDavid MacKay, Kornelia Grein, Isaura Duarte, Jill Kieffer, Jordi Torren Edo, Ana Rodrigues Sanchez Beato (European Medicines Agency)Quarterly Bilateral Meeting
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine6/11/10Rockville, MDTracey Forfa, William Flynn, Steve Vaughn, Margaret Oeller, Dave White, Dan McChesneyJoel Brandenberger, Anne Willis, Hilary Thesmar, Beth Johnson (National Turkey Federation)Drug Approval Process
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs6/8/10Washington, DCN/ADouglas Peddicord, John Lewis, Katherine Madigan, Leila Mendelovici, Kyle Peddicord (ACRO); Judith Beach (Quintiles); Joe Herring (Covance); Susan Gagnon (ICON); Bruce Garrett (GRS); Glenn Kerkhof (Chiltern); Judd Hartman, William Sharbaugh, Lisa Noecker, Daisy DeWeese-Gatt (PPD); Jeffrey McMullen (PharmaNet); Douglas Batt (PAREXEL); Jerry Schafer (Whiteford, Taylor, Preston)Global Clinical Research
Beth Martino, Associate Commissioner for External Affairs6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health6/8/10Silver Spring, MDAlberto Gutierrez, Nancy Stade, David MedrickEd Basile, Dee Mellor, Patricia Kaeding (GE Healthcare)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health6/11/10Silver Spring, MDAlberto GutierrezBud Tribble, Cathy Novelli (Apple, Inc.)Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel6/11/10Silver Spring, MDN/AAmy Schulman, Jeffrey B. Chasnow (Pfizer)Courtesy Visit
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs6/7/10-
6/11/10
N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/8/10Silver Spring, MDTheresa Mullin, Susan McCune, Charles CooperRay Woosley, Steve Broadbent (Critical Path Institute)Collaborations with FDA
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/9/10Washington, DCKaren RileyFrank Pallone (Subcommittee on Health)Develoment of New Antibiotics for Humans
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/9/10Washington, DCRachel Behrman, Melissa RobbDavid Wheadon, Tom ScarnecchiaScientific and Regulatory Affairs Executive Committee Meeting
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research6/11/10Washington, DCJane Axelrad, Chalres GanleyN/ABriefing on Sunscreens